Home » Posts tagged "上海外卖自带工作室微信号"

Mission Valley League Football Preview: Marshall Faces Toughest Test Yet; Eagles Visit First-Place Arroyo Friday

first_img Marshall gets its quickest and toughest shot at getting back into the Mission Valley League race.The Eagles (4-2, 1-1) travel to take on Arroyo (6-1, 3-0) against a Knights team that has allowed just 27 total points in their three MVL games thus far.Not only has Arroyo won its three MVL games, they’ve beaten the next best teams in league (El Monte, South El Monte and Rosemead).“We have to (try and) play flawless football,” Marshall coach Scott Faer said. “We can’t have stupid penalties or put the ball on the ground like we have the last couple of weeks. Arroyo is fundamentally sound and just play good team football.”DJ Paul, Jonathon Frimpong and Andrew Kanamu all gained over 100 yards in last week’s victory over Mountain View, and they’ll need to repeat that on Friday if an upset is in order.“Our speed guys have to hit a couple home runs,” Faer said. (On defense) “We can’t give up the home run ball and have to make them earn every touchdown. We have to make them nickel-and-dime us down the field.”Mission Valley League Standings:Arroyo (6-1 overall, 3-0 in league)El Monte (4-3, 2-1)Rosemead (2-5, 2-1)South El Monte (5-2, 1-1)Marshall (4-2, 1-1)Gabrielino (2-4, 0-2)Mountain View (2-5, 0-3) Pasadena’s ‘626 Day’ Aims to Celebrate City, Boost Local Economy More Cool Stuff Home of the Week: Unique Pasadena Home Located on Madeline Drive, Pasadena Your email address will not be published. Required fields are marked * Make a comment Business News Get our daily Pasadena newspaper in your email box. Free.Get all the latest Pasadena news, more than 10 fresh stories daily, 7 days a week at 7 a.m. EVENTS & ENTERTAINMENT | FOOD & DRINK | THE ARTS | REAL ESTATE | HOME & GARDEN | WELLNESS | SOCIAL SCENE | GETAWAYS | PARENTS & KIDS Community News Pasadena Will Allow Vaccinated People to Go Without Masks in Most Settings Starting on Tuesday center_img 0 commentsShareShareTweetSharePin it Top of the News Community News First Heatwave Expected Next Week Name (required)  Mail (required) (not be published)  Website  Subscribe Sports Mission Valley League Football Preview: Marshall Faces Toughest Test Yet; Eagles Visit First-Place Arroyo Friday By BRIAN REED-BAIOTTO, Sports Editor Published on Wednesday, October 12, 2016 | 6:59 pm faithfernandez More » ShareTweetShare on Google+Pin on PinterestSend with WhatsApp,Virtual Schools PasadenaHomes Solve Community/Gov/Pub SafetyCitizen Service CenterPASADENA EVENTS & ACTIVITIES CALENDARClick here for Movie Showtimes HerbeautyThis Trend Looks Kind Of Cool!HerbeautyHerbeautyHerbeautyStop Eating Read Meat (Before It’s Too Late)HerbeautyHerbeautyHerbeautyAt 9 Years Old, This Young Girl Dazzled The World Of FashionHerbeautyHerbeautyHerbeauty7 Most Startling Movie Moments We Didn’t Realize Were InsensitiveHerbeautyHerbeautyHerbeauty8 Yoga Poses To Overcome Stress And AnxietyHerbeautyHerbeautyHerbeautyInstall These Measures To Keep Your Household Safe From Covid19HerbeautyHerbeautylast_img read more

Continue reading »

ND brain researcher receives NFL grant

first_imgThe National Football League (NFL) will fund Notre Dame’s chemistry and biochemistry departments to research strokes and other brain injuries, professor Mayland Chang said. Chang, who has been working on the project for 15 years, studies gelatinase-based brain diseases. Funded in part by the National Institute of Health, the researched treatments are getting close to FDA trials, she said. Gelatinase is a type of enzyme that breaks down cell walls and can cause tumor metastasis in cancer, as well as problems in traumatic brain injury (TBI), strokes, aneurysms and diabetic wounds. Chang’s husband, professor Shahriar Mobashery, discovered a compound at Wayne State University called SB-3CT that could be a possible treatment for the brain diseases. Mobashery now teaches at Notre Dame. The SB-3CT compound is an inhibitor triggered by the enzyme’s reaction in the cell. Chang said a compound like SB-3CT could help stop brain damage similarly to how it helps stroke patients. The compound was synthesized more than 450 times to find a way to make it water soluble, so it can be put into an IV or given to a patient in the form of an injection, Chang said. If all goes well, the drug could be in use with stroke patients in seven to nine years, Chang said. “Would this be great to have as an injectable treatment?” she said. “It could be on the sidelines. If you get a concussion, you can get a shot. This is eventually our hope.” The current drug used to dissolve clots in ischemic, or clot-forming, stroke patients is tissue Plasminogen Activator, or tPA, Chang said. This drug dissolves the clot, but increases gelatinase enzymes, which causes hemorrhaging and brain swelling. When SB-3CT is given in tandem with this drug in experiments, it has reduced side affects. Researchers have developed an experimental model to test compounds. “We’re always looking for better ways to treat,” she said. Chang, whose son is a competitive snow boarder, witnessed the treatment for TBI when her son had a concussion last year. “If you have a concussion, they can do cognitive treatment,” she said. “They do simple things. For example, they ask you to list words that begin with the same letter. They also make you take a rest — no physical activity, nothing to rattle your brain. They don’t really do anything else.” The research team is currently searching for funding to have toxicology studies done, which will then put the drug into FDA clinical trials, Chang said. She said the team hopes the compound will improve emergency response to brain problems. “Given in an ambulance setting, it would work quickly,” she said.last_img read more

Continue reading »